Patients with cardiac ailments are sometimes treated with heart pumps adapted to be inserted into the heart through adjoining blood vessels and configured to assist the natural cardiac pump function or to replace natural cardiac pump function by a continuous pumping operation.
In one common approach, an introducer sheath is used to gain vascular access prior to insertion of a medical device such as a heart pump. The introducer sheath includes a hemostatic valve that prevents blood leakage from the proximal end of the introducer sheath upon insertion of the introducer sheath into a blood vessel. The hemostatic valve should prevent excessive blood leakage when no objects are present in the valve or when guidewires, catheters, blood pumps, or other objects are inserted through the valve. One of the primary causes of excess leakage in an introducer sheath is damage to or perforation of the hemostatic valve.
Disclosed herein is an introducer sheath for percutaneous insertion of a heart pump. The introducer sheath includes a guide and a hemostatic valve. The introducer sheath guides an object towards the center of the hemostatic valve to reduce the risk of inadvertently puncturing the hemostatic valve during insertion of the object (e.g., a heart pump). Such inadvertent punctures could result when the object is inserted into the hemostatic valve at a position that is away/laterally offset from the center of the hemostatic valve or angularly offset from a central longitudinal axis of the hemostatic valve, thereby increasing the risk of damage to the hemostatic valve. The guide may be formed from the hemostatic valve or as a separate element. The systems, methods, and devices described herein reduce or eliminate the risk of valve perforation during insertion of medical devices (e.g., heart pumps), guidewires, dilators, or other objects by guiding inserted objects toward the center of the hemostatic valve. This can reduce or prevent blood leakage through the hemostatic valve.
The hemostatic valve will additionally simplify user interaction with the introducer sheath. Current systems, methods, and devices may require a pre-requisite level of experience or attention from a user during a preparation phase, or during insertion of medical devices (e.g., heart pumps), guidewires, dilators, or other objects. However the proposed introducer sheath would improve ease of use with the system without requiring such pre-requisite levels of experience or attention from a user. Additionally, performance of the introducer sheath would be independent of the location on the hemostatic valve at which medical devices (e.g., heart pumps) are inserted. This minimizes human factor considerations and accommodates a wider range of use conditions.
In one aspect, an introducer for insertion of a medical device into a patient's vasculature includes an elongate introducer body, a hub, and a hemostatic valve. The elongate introducer body includes a longitudinal axis, a proximal region, a distal region, and an inner lumen. The hub is coupled to the proximal region of the introducer body. The hemostatic valve is disposed within the hub and forms a liquid-tight seal across the inner lumen. The hemostatic valve includes a guide configured to guide an object towards the center of the valve during insertion of the object. The guide may be a funnel. In some implementations, the hemostatic valve has a proximal surface and a distal surface, and the funnel is defined by sloped regions of the proximal surface of the hemostatic valve. The funnel may be separate from the hemostatic valve. The sloped regions may be angled about 30°, about 45°, about 60°, or greater relative to the plane perpendicular to the longitudinal axis of the introducer body. In certain implementations, the proximal surface includes a flat central region that is substantially perpendicular to the longitudinal axis of the elongate introducer body. The flat central region may have a diameter of about 3 mm or less. In some implementations, the introducer is configured to part along a parting surface substantially parallel to the longitudinal axis of the introducer body. In certain implementations, the hemostatic valve is configured to part along a parting surface substantially parallel to the longitudinal axis of the introducer body. The hemostatic valve may include a central void that reduces the stiffness of the center of the hemostatic valve.
The foregoing and other objects and advantages will be apparent upon consideration of the following detailed description, taken in conjunction with the accompanying drawings, in which like reference characters refer to like parts throughout, and in which:
To provide an overall understanding of the systems, method, and devices described herein, certain illustrative embodiments will be described. Although the embodiments and features described herein are specifically described for use in connection with introducer sheaths and hemostatic valves for percutaneous insertion of heart pumps, it will be understood that all the components and other features outlined below may be combined with one another in any suitable manner and may be adapted and applied to other types of introducer sheaths and hemostatic valves or other types of cardiac assist devices, including balloon pumps.
The apparatus described herein provides an introducer sheath and a hemostatic valve for percutaneous insertion of a heart pump. The introducer sheath includes a guide and a hemostatic valve. The introducer sheath guides an object towards the center of the hemostatic valve to reduce the risk of inadvertently puncturing the hemostatic valve during insertion of the object (e.g., a heart pump). The guide may be formed from the hemostatic valve or as a separate element. The systems, methods, and devices described herein thus reduce or eliminate the risk of valve perforation during insertion of medical devices heart pumps), guidewires, dilators, or other objects. This can reduce or prevent blood leakage through the hemostatic valve.
The hemostatic valve 104 creates a liquid tight seal across the inner lumen 107 of the elongate introducer body 106. The guide 110 of the hemostatic valve 104 guides objects inserted into the hemostatic valve 104 such that the objects are guided to the central flat region 114. This reduces the risk of inadvertently puncturing the hemostatic valve 104 during insertion of an object (e.g., a heart pump). The guide 110 includes a first guide portion 110a and a second guide portion 110b. The guide 110 is formed by the proximal surface 112 of the hemostatic valve 104. The proximal surface 112 includes the sloped region 113, which defines the funneled shape of the guide 110, and the central flat region 114. The sloped region 113 is angled relative to the central flat region 114 by a funnel angle 117. The funnel angle 117 is about 30°. In some implementations, the funnel angle is about 10°, 15°, 20°, 25°, 30°, 35°, 40°, 45°, 50°, 55°, 60°, 65°, 70°, 75°, 80°, 85°, or any other suitable angle. The funnel angle 117 is suitably steep to guide inserted objects towards the central flat region 114. The funnel angle 117 is shown as substantially constant in
The hemostatic valve 104 is formed of the first hemostatic valve portion 104a and the second hemostatic valve portion 104b. The first hemostatic valve portion 104a and the second hemostatic valve portion 104b are held together by the hub 102 and interface at the parting surface 116. The parting surface 116 separating the first hemostatic valve portion 104a and the second hemostatic valve portion 104b allow the hemostatic valve 104 to be completely separated after insertion of an object. The first hemostatic valve portion 104a is connected to the first hub portion 102a at the outer region 120a, and the second hemostatic valve portion 104b is connected to the second hub portion 102b at the outer region 120b. The connection between the hub 102 and the hemostatic valve 104 may be an interference fit, an adhesive bond, a connection by a mechanical fastener, or any other suitable connection. The parting surface 116 also defines a central void 118. The central void 118 reduces the stiffness of the hemostatic valve 104 in the central flat region 114. This may allow the valve to easily give or to deform in the central flat region 114 when an object is inserted. This may also allow the hemostatic valve 104 to form a double seal against an object inserted through the hemostatic valve 104. A double seal may provide redundancy, thereby decreasing the risk of valve leakage or failure.
The hemostatic valve 104 is coupled to the elongate introducer body 106 by the hub 102. Similar to the hemostatic valve 104, the hub 102 is split along the parting surface 116 into the first hub portion 102a and the second hub portion 102b. The first and second wings 103a-b provide a lever arm that allows the hub 102 to be manually split into the first hub portion 102a and the second hub portion 102b. This splitting may facilitate the replacement of the introducer assembly 100 with another assembly or sheath during the use of a heart pump. Splitting of the hub 102 also initiates splitting of the elongate introducer body 106 into two parts so that the entire introducer assembly 100 can be removed as will be discussed further in relation to
In introducer assembly 300, the distal surface 311 and the proximal surface 312 of the hemostatic valve 304 are both substantially flat. A hemostatic valve 304 having a substantially flat profile would less material and complexity to manufacture and implement. The hub 302 also includes a bracket 325 comprising a first bracket portion 325a and a second bracket portion 325b. A guide 310 is integrally formed with the bracket 325 and comprises a first guide portion 310a and second guide portion 310b that define a central opening 314. The bracket 325 substantially encompasses the hemostatic valve 304 such that a portion 320a and 320b of the proximal surface 312 of the hemostatic valve 304 is in contact with the guide portions 310a and 310b of the bracket 325. In this configuration, the guide 310 exposes a portion of the substantially flat proximal surface 312 of the hemostatic valve 304 in the vicinity of the central opening 314.
The guide 310 includes a sloped region 313, which defines the funneled shape of the guide 310 and the central opening 314, which, in turn, exposes the substantially flat proximal surface 312 of the hemostatic valve 304. The guide 310 is therefore able to guide objects towards the central opening 314 and hence the proximal surface 312 of hemostatic valve 304. The sloped region 313 is angled relative to the exposed flat proximal surface 312 of the hemostatic valve 304 by a funnel angle 317. The funnel angle 317 is about 30°. In some implementations, the funnel angle 317 is about 10°, 15°, 20°, 25°, 30°, 35°, 40°, 45°, 50°, 55°, 60°, 65°, 70°, 75°, 80°, 85°, or any other suitable angle. The funnel angle 317 is suitably steep to guide inserted objects towards the central opening 314 and the flat proximal surface 312 of the hemostatic valve 304. The funnel angle 317 is shown as substantially constant in
The hemostatic valve 304 is formed of the first hemostatic valve portion 304a and the second hemostatic valve portion 304b. The first hemostatic valve portion 304a and the second hemostatic valve portion 304b are held together by the bracket 325 in the hub 302 and interface at the parting surface 316. The parting surface 316 separating the first hemostatic valve portion 304a and the second hemostatic valve portion 304b allow the hemostatic valve 304 to be completely separated after insertion of an object. The first hemostatic valve portion 304a is connected to the first bracket portion 325a at the portion 320a of the proximal surface 312 of the hemostatic valve 304, while the second hemostatic valve portion 304b is connected to the second bracket portion 325b at the portion 320b of the proximal surface 312. The connection between the bracket 325 and the hemostatic valve 304 may be an interference fit, an adhesive bond, a connection by a mechanical fastener, or any other suitable connection. The parting surface 316 also defines a central void 318. The central void 318 reduces the stiffness of the hemostatic valve 304 in the vicinity of the central opening 314. This may allow the valve to easily give or to deform in the vicinity of the central opening 314 when an object is inserted. This may also allow the hemostatic valve 304 to form a double seal against an object inserted through the hemostatic valve 304. A double seal may provide redundancy, thereby decreasing the risk of valve leakage or failure.
Similar to the hemostatic valve 304, the hub 302 and bracket 325 are split along the parting surface 316 into the first hub portion 302a and first bracket portion 325a, and the second hub portion 302b and second bracket portion 3251. The first and second wings 303a-b provide a lever arm that allows the hub 302 and guide 310 to be manually split into the first hub portion 302a the first bracket portion 325a, and the second hub portion 302b and the second bracket portion 325b. This splitting may facilitate the replacement of the introducer assembly 300 with another assembly or sheath during the use of a heart pump. Splitting of the hub 302 also initiates splitting of the elongate introducer body 306 into two parts so that the entire introducer assembly 300 can be removed as previously discussed in relation to
The reinforcing ring 150 discussed in relation to
In a further alternate implementation, the guide portion 310 may be located in the reinforcing ring 150.
The foregoing is merely illustrative of the principles of the disclosure, and the apparatuses can be practiced by other than the described embodiments, which are presented for purposes of illustration and not of limitation. It is to be understood that the apparatuses disclosed herein, while shown for use in percutaneous insertion of heart pumps, may be applied to apparatuses in other applications requiring hemostasis.
Variations and modifications will occur to those of skill in the art after reviewing this disclosure. The disclosed features may be implemented, in any combination and subcombination (including multiple dependent combinations and subcombinations), with one or more other features described herein. The various features described or illustrated above, including any components thereof, may be combined or integrated in other systems. Moreover, certain features may be omitted or not implemented.
Examples of changes, substitutions, and alterations are ascertainable by one skilled in the art and could be made without departing from the scope of the information disclosed herein. All references cited herein are incorporated by reference in their entirety and made part of this application.
This application is a continuation of U.S. patent application Ser. No. 15/245,982, filed Aug. 24, 2016 (now U.S. Pat. No. 10,576,258), which claims the benefit of U.S. Provisional Patent Application No. 62/209,288, filed on Aug. 24, 2015, which are hereby incorporated herein by reference in its entirety.
Number | Name | Date | Kind |
---|---|---|---|
5312355 | Lee | May 1994 | A |
6551283 | Guo et al. | Apr 2003 | B1 |
6712791 | Lui et al. | Mar 2004 | B2 |
7241276 | Argentine et al. | Jul 2007 | B2 |
8147456 | Fisher et al. | Apr 2012 | B2 |
20030171721 | Enomoto et al. | Sep 2003 | A1 |
20040267202 | Potter | Dec 2004 | A1 |
20050010238 | Potter et al. | Jan 2005 | A1 |
20050033239 | Argentine | Feb 2005 | A1 |
20060145116 | Rickerd et al. | Jul 2006 | A1 |
20090012476 | Catlin | Jan 2009 | A1 |
20090234290 | Fisher et al. | Sep 2009 | A1 |
20100100044 | Ye et al. | Apr 2010 | A1 |
20100241083 | Fisher et al. | Sep 2010 | A1 |
20110152763 | Bishop et al. | Jun 2011 | A1 |
20120221024 | Sutton et al. | Aug 2012 | A1 |
20130046241 | Okamura et al. | Feb 2013 | A1 |
20160008803 | Jost | Jan 2016 | A1 |
20200241083 | Franke | Jul 2020 | A1 |
Number | Date | Country |
---|---|---|
H0187746 | Jun 1989 | JP |
H0639011 | Feb 1994 | JP |
H06154336 | Jun 1994 | JP |
H10127775 | May 1998 | JP |
H114893 | Jan 1999 | JP |
H11128359 | May 1999 | JP |
2003520652 | Jul 2003 | JP |
2004208853 | Jul 2004 | JP |
2007533341 | Nov 2007 | JP |
2011510686 | Apr 2011 | JP |
2011130846 | Jul 2011 | JP |
2011212417 | Oct 2011 | JP |
2016510686 | Apr 2016 | JP |
0154763 | Aug 2001 | WO |
2005016180 | Feb 2005 | WO |
2009002828 | Dec 2008 | WO |
2009038727 | Mar 2009 | WO |
2013005607 | Jan 2013 | WO |
2016055368 | Apr 2016 | WO |
2020135607 | Jul 2020 | WO |
Entry |
---|
Office Action issued in corresponding Japanese Application No. 2018-510515 dated Aug. 31, 2020 (10 pages). |
Office Action issued in corresponding Indian Application No. 201817008180 dated Feb. 2, 2021 (6 pages). |
Extended European Search Report for EP Application No. 20201854.5 dated Oct. 19, 2020 (10 pages). |
Office Action in corresponding Australian Patent Application No. 2021200363 dated Apr. 26, 2022 (6 pp.). |
Notice of Reasons for Revocation from corresponding Japanese Patent No. 6956069 dated Sep. 9, 2022 (32 pages). |
Office Action from corresponding Japanese Application No. 2021-163179 dated Oct. 24, 2022 (8 pages). |
International Search Report dated Nov. 10, 2016 for International Application No. PCT/US2016/048459, filed Aug. 24, 2016. |
Supplementary EP Search Report, EP 16 84 0060 dated Apr. 16, 2019. |
Number | Date | Country | |
---|---|---|---|
20200276432 A1 | Sep 2020 | US |
Number | Date | Country | |
---|---|---|---|
62209288 | Aug 2015 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 15245982 | Aug 2016 | US |
Child | 16784329 | US |